A
TSVT

AJOVista’s 2seventy bio TSVT Stock Holding History

AJOVista’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$95.6K Buy
+20,255
New +$91.3K 0.41% 77

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

AJOVista's TSVT Position: Q3 2024 in Review

AJOVista opened a new position in 2seventy bio (TSVT) in Q3 2024: 20,255 shares worth $95.6K. The stake represents 0.41% of the portfolio and ranks #77 among its holdings.

115 funds tracked by Wall St. Rank hold TSVT as of Q3 2024.

  • AJOVista held 20,255 shares of 2seventy bio worth $95.6K as of Q3 2024.
  • 2seventy bio was a new AJOVista position in Q3 2024.
  • 2seventy bio made up 0.41% of AJOVista's portfolio in Q3 2024, its #77 holding.
  • 115 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2024.

Based on AJOVista's 13F filing for Q3 2024, filed 12 Nov 2024.